84711-20-6 (异环磷酰胺,IFOSFAMIDE)

快速询单

结构式：

异环磷酰胺MOL文件

CAS号：

84711-20-6

中文名称：

异环磷酰胺

英文名称：

IFOSFAMIDE

分子式：

C₇H₁₅Cl₂N₂O₂P

分子量：

261.085960626602

异环磷酰胺(84711-20-6)名称与标识符

名称

中文别名：

异环磷酰胺;

英文别名：

IFOSFAMIDE;

标识符

InChIKey：

HOMGKSMUEGBAAB-UHFFFAOYSA-N

Inchi：

1S/C7H15Cl2N2O2P/c8-2-4-10-14(12)11(6-3-9)5-1-7-13-14/h1-7H2,(H,10,12)

SMILES：

ClC([H])([H])C([H])([H])N1C([H])([H])C([H])([H])C([H])([H])OP1(N([H])C([H])([H])C([H])([H])Cl)=O

异环磷酰胺(84711-20-6)物化性质

实验特性

LogP : 2.21280
PSA : 51.38000
熔点 : 39-41 deg C

计算特性

精确分子量 : 260.02482
氢键供体数量 : 1
氢键受体数量 : 4
可旋转化学键数量 : 5
同位素质量 : 260.02482
重原子数量 : 14
复杂度 : 218
同位素原子数量 : 0
确定原子立构中心数量 : 0
不确定原子立构中心数量 : 1
确定化学键立构中心数量 : 0
不确定化学键立构中心数量 : 0
共价键单元数量 : 1
疏水参数计算参考值（XlogP） : 0.9
拓扑分子极性表面积 : 41.6

异环磷酰胺(84711-20-6)推荐厂家更多厂家(1)

公司名称	手机号/电话	联系人	QQ	微信	询单
Zhejiang Wonderful Pharma & Chem Co., Ltd.					询单

异环磷酰胺(84711-20-6)相关文献

1. Source to sink tracking of selected human pharmaceuticals from two Oslo city hospitals and a wastewater treatment works
Kevin V. Thomas,Christian Dye,Martin Schlabach,Katherine H. Langford J. Environ. Monit. 2007 9 1410
2. Separation of ifosfamide and its degradation products using micellar electrokinetic chromatography
Shannon Hill,John Aexiou,Peter E. Kavanagh,Peter C. Livingstone,Ross A. Shalliker,James Soscic Anal. Commun. 1996 33 235
3. Multi-residue determination of micropollutants in Nigerian fish from Lagos lagoon using ultrasound assisted extraction, solid phase extraction and ultra-high-performance liquid chromatography tandem mass spectrometry
Idera Fabunmi,Natalie Sims,Kathryn Proctor,Aderonke Oyeyiola,Temilola Oluseyi,Kehinde Olayinka,Barbara Kasprzyk-Hordern Anal. Methods 2020 12 2114
4. Glucose conjugation for the specific targeting and treatment of cancer
Emilia C. Calvaresi,Paul J. Hergenrother Chem. Sci. 2013 4 2319
5. Theoretical use of boron nitride nanotubes as a perfect container for anticancer molecules
M. El Khalifi,E. Duverger,T. Gharbi,H. Boulahdour,F. Picaud Anal. Methods 2016 8 1367
6. Microfluidic lumen-based systems for advancing tubular organ modeling
María Virumbrales-Mu?oz,José M. Ayuso,Max M. Gong,Mouhita Humayun,Megan K. Livingston,Karina M. Lugo-Cintrón,Patrick McMinn,Yasmín R. álvarez-García,David J. Beebe Chem. Soc. Rev. 2020 49 6402
7. Pharmacologically active compounds in the environment and their chirality
Barbara Kasprzyk-Hordern Chem. Soc. Rev. 2010 39 4466
8. A proteome-wide systems toxicological approach deciphers the interaction network of chemotherapeutic drugs in the cardiovascular milieu
Suvendu Giri,Jeganathan Manivannan,Bhuvaneswari Srinivasan,Lakshmikirupa Sundaresan,Palanivel Gajalakshmi,Suvro Chatterjee RSC Adv. 2018 8 20211
9. Polymer microcapsules and microbeads as cell carriers for in vivo biomedical applications
Barbara Kupikowska-Stobba,Dorota Lewińska Biomater. Sci. 2020 8 1536
10. Removal of pharmaceuticals by a potassium ferrate(vi) material: from practical implementation to reactivity prediction
Vanessa Peings,Thierry Pigot,Patrick Baylere,Jean-Marc Sotiropoulos,Jér?me Frayret Environ. Sci.: Water Res. Technol. 2017 3 699